ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Artofdragon
|
21K |
7.3M |
13 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
21K
|
7.3M
|
13
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Investor Presentation - RIU Explorers Conference 2023
|
|
Artofdragon
|
54 |
24K |
2 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
54
|
24K
|
2
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Investor Presentation - RIU Explorers Conference 2023
|
|
Artofdragon
|
54 |
24K |
5 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
54
|
24K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
Artofdragon
|
24 |
7.5K |
3 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
24
|
7.5K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Artofdragon
|
1.7K |
617K |
34 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
1.7K
|
617K
|
34
|
|
ASX - By Stock
|
ATX |
ATX media coverage
|
|
Artofdragon
|
1 |
770 |
3 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
1
|
770
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Artofdragon
|
1.7K |
617K |
23 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
1.7K
|
617K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Artofdragon
|
1.7K |
617K |
14 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
1.7K
|
617K
|
14
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Artofdragon
|
21K |
7.3M |
6 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
21K
|
7.3M
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to Cohort 2 of Accent Trial
|
|
Artofdragon
|
8 |
2.9K |
10 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
8
|
2.9K
|
10
|
|
ASX - By Stock
|
IPT |
Re:
IPT Chart
|
|
Artofdragon
|
477 |
195K |
6 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
477
|
195K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Artofdragon
|
11K |
3.8M |
6 |
28/01/23 |
28/01/23 |
General
|
11K
|
3.8M
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
Artofdragon
|
24 |
7.5K |
0 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
24
|
7.5K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
Artofdragon
|
24 |
7.5K |
1 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
24
|
7.5K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Artofdragon
|
11K |
3.8M |
19 |
04/01/23 |
04/01/23 |
General
|
11K
|
3.8M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: December 2022 Preclinical & Clinical Programs Update
|
|
Artofdragon
|
12 |
7.8K |
22 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
12
|
7.8K
|
22
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Letter to Shareholders End of Year Summary and 2023 Plans
|
|
Artofdragon
|
2 |
1.7K |
6 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
2
|
1.7K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
share price
|
|
Artofdragon
|
32 |
9.7K |
1 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
32
|
9.7K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
Artofdragon
|
24 |
7.5K |
2 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
24
|
7.5K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
share price
|
|
Artofdragon
|
32 |
9.7K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
32
|
9.7K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
share price
|
|
Artofdragon
|
32 |
9.7K |
2 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
32
|
9.7K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
share price
|
|
Artofdragon
|
32 |
9.7K |
2 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
32
|
9.7K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Appoints Dr Christopher Burns CEO & Managing Director
|
|
Artofdragon
|
4 |
1.5K |
4 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
4
|
1.5K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities and Cashflow Reports - Sep 2022 Qtr
|
|
Artofdragon
|
6 |
2.6K |
2 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
6
|
2.6K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
Artofdragon
|
58 |
19K |
3 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
58
|
19K
|
3
|
|
ASX - By Stock
|
IPT |
Re:
IPT Chart
|
|
Artofdragon
|
477 |
195K |
4 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
477
|
195K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AMP886 Activity in Acute Myeloid Leukemia
|
|
Artofdragon
|
5 |
2.2K |
5 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
5
|
2.2K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: CEO Resignation
|
|
Artofdragon
|
22 |
6.9K |
3 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
22
|
6.9K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: CEO Resignation
|
|
Artofdragon
|
22 |
6.9K |
4 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
22
|
6.9K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
Artofdragon
|
58 |
19K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
58
|
19K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
Artofdragon
|
58 |
19K |
7 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
58
|
19K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
Artofdragon
|
58 |
19K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
58
|
19K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
|
|
Artofdragon
|
58 |
19K |
3 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
58
|
19K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Artofdragon
|
11K |
3.8M |
19 |
15/06/22 |
15/06/22 |
General
|
11K
|
3.8M
|
19
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Artofdragon
|
11K |
3.8M |
9 |
14/06/22 |
14/06/22 |
General
|
11K
|
3.8M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Artofdragon
|
438 |
177K |
4 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
438
|
177K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AMP945 Shows Efficacy in Model of Lung Fibrosis
|
|
Artofdragon
|
11 |
4.5K |
7 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
11
|
4.5K
|
7
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Valuation- Amplia is a sleeping giant
|
|
Artofdragon
|
46 |
21K |
4 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
46
|
21K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Receives Second Ethics Clearance for Phase 2 Trial
|
|
Artofdragon
|
9 |
3.5K |
7 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
9
|
3.5K
|
7
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Valuation- Amplia is a sleeping giant
|
|
Artofdragon
|
46 |
21K |
6 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
46
|
21K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AMP945 Pre-IND Meeting Outcome
|
|
Artofdragon
|
8 |
2.0K |
4 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
8
|
2.0K
|
4
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Renounceable Rights Issue to Raise up to $6 Million
|
|
Artofdragon
|
95 |
52K |
2 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
95
|
52K
|
2
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Renounceable Rights Issue to Raise up to $6 Million
|
|
Artofdragon
|
95 |
52K |
0 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
95
|
52K
|
0
|
|
ASX - By Stock
|
ATX Biotech |
Re:
Valuation- Amplia is a sleeping giant
|
|
Artofdragon
|
46 |
21K |
5 |
01/05/22 |
01/05/22 |
ASX - By Stock
|
46
|
21K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Artofdragon
|
438 |
177K |
8 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
438
|
177K
|
8
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Trading Halt
|
|
Artofdragon
|
53 |
16K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
53
|
16K
|
0
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Trading Halt
|
|
Artofdragon
|
53 |
16K |
9 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
53
|
16K
|
9
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Outstanding Soil Geochemistry Results for Jumbo Project
|
|
Artofdragon
|
12 |
4.8K |
1 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
12
|
4.8K
|
1
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Outstanding Soil Geochemistry Results for Jumbo Project
|
|
Artofdragon
|
12 |
4.8K |
7 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
12
|
4.8K
|
7
|
|
ASX - By Stock
|
IPT |
Re:
PGM's breaking out
|
|
Artofdragon
|
31 |
11K |
5 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
31
|
11K
|
5
|
|